A Life Sciences Investment Firm & Valued Strategic and Execution Partner
Invests in entrepreneur scientists working on platform technologies across services, therapeutics, and diagnostics to address large, unmet medical needs in oncology, neurosciences, and rare diseases.
Invest in entrepreneurs with disruptive technologies across therapeutics, services, vaccines, and diagnostics to bring their innovations to market and address other solutions for the growing burden of AMR.
Kineticos brought a methodical approach, experienced resources, and industry contacts to help advance our projects to a swift conclusion.
Bob Jones, CEO, Acura Pharmaceuticals
The insights Kineticos provided on a strategic portfolio assessment were highly actionable, and we have implemented a new strategy based on the findings – a hugely successful project!
Oliver Schacht, CEO, OpGen
Our strategic work with Kineticos provided us immense fire power to reach out to biopharmaceutical companies interested in partnering our gene, CRISPR and cell therapy programs.
Oscar Segurado, CMO, ASC Therapeutics
We engaged with Kineticos to research a new market for a potential investment. The insights were immediately actionable, the team was highly responsive, and communication was excellent.
David Anderson, General Partner, Ampersand
On numerous occasions the Kineticos team has promptly and diligently conducted market research through KOLs and data driven insights.”
Mark Bamforth, CEO, Arranta Bio
News
Contact Us
If you are seeking help, more information, or would like to discuss your next initiative with our experts, contact us today.
Kineticos Life Sciences
9131 Anson Way
Suite 110
Raleigh, NC 27615
USA